{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:24:05Z","timestamp":1787171045932,"version":"build-2736575974"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1185","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RRNPSF-Jul23\/100005"],"award-info":[{"award-number":["RRNPSF-Jul23\/100005"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Manchester Biomedical Research Center","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Spatially fractionated radiotherapy in the form of a lattice of high-dose regions within the tumor has potential to improve the therapeutic response compared to standard radiotherapy. We aimed (1) to develop and dosimetrically validate a proton pencil-beam scanning lattice radiotherapy (LRT) planning technique, (2) to compare against a photon VMAT LRT technique, and (3) to assess which clinical sites are feasible for treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>10 cases were selected, covering sites in the brain, neck, pelvis, abdomen and shoulder with gross tumor volumes greater than 100\u2009cm3. LRT plans were developed for a Varian ProBeam system, aiming to deliver 20\u2009Gy to the lattice vertices while minimizing dose to surrounding tissues. Plan-specific quality assurance (PSQA) was performed by independent Monte-Carlo calculation and physical dosimetric verification. End-to-end tests were performed using a CIRS head phantom containing EBT4 film. Plan quality was evaluated against VMAT LRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinically acceptable proton LRT plans were produced, delivering 16-20\u2009Gy to the lattice vertices, a mean PTV dose of 2\u2009Gy and satisfying organ-at-risk dose constraints. PSQA and end-to-end tests met clinical tolerances for non-LRT plans. For large target volumes, proton LRT produced lattices with a greater number of vertices than VMAT LRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Proton LRT is technically viable using currently available delivery systems. Large tumors such as sarcoma are the most likely candidates for future clinical studies, but proton LRT is feasible for target volumes as small as 100\u2009cm3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Advances in knowledge<\/jats:title>\n                    <jats:p>The study demonstrates the feasibility of proton LRT for early phase clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjr\/tqag125","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T18:01:08Z","timestamp":1779732068000},"page":"1806-1819","source":"Crossref","is-referenced-by-count":1,"title":["Proton pencil beam scanning lattice radiotherapy: technical implementation and comparison against photon-based delivery"],"prefix":"10.1093","volume":"99","author":[{"given":"Abdul S","family":"Khalid","sequence":"first","affiliation":[{"name":"Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC) , Manchester M20 4BX,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-5761","authenticated-orcid":false,"given":"Adam H","family":"Aitkenhead","sequence":"additional","affiliation":[{"name":"Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC) , Manchester M20 4BX,","place":["United Kingdom"]},{"name":"Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester , Manchester M13 9PL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7685-8156","authenticated-orcid":false,"given":"Matthew","family":"Lowe","sequence":"additional","affiliation":[{"name":"Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC) , Manchester M20 4BX,","place":["United Kingdom"]},{"name":"Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester , Manchester M13 9PL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Clarke","sequence":"additional","affiliation":[{"name":"Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC) , Manchester M20 4BX,","place":["United Kingdom"]},{"name":"Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester , Manchester M13 9PL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-7759","authenticated-orcid":false,"given":"John-William","family":"Warmenhoven","sequence":"additional","affiliation":[{"name":"Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC) , Manchester M20 4BX,","place":["United Kingdom"]},{"name":"Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester , Manchester M13 9PL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9783-2062","authenticated-orcid":false,"given":"Francesca","family":"Fiorini","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Physics, Churchill Hospital, Oxford University Hospitals NHS Trust , Oxford OX3 7LE,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6981-4335","authenticated-orcid":false,"given":"Thomas W S","family":"Satherley","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Physics, Churchill Hospital, Oxford University Hospitals NHS Trust , Oxford OX3 7LE,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Physics, Churchill Hospital, Oxford University Hospitals NHS Trust , Oxford OX3 7LE,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-909X","authenticated-orcid":false,"given":"Geoff S","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford , Oxford OX3 7DQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0300-5790","authenticated-orcid":false,"given":"Kristoffer","family":"Petersson","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford , Oxford OX3 7DQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"2026081915320558100_tqag125-B1","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/erm.2021.34","article-title":"Divide and conquer: spatially fractionated radiation therapy","volume":"24","author":"Prezado","year":"2022","journal-title":"Expert Rev Mol Med"},{"key":"2026081915320558100_tqag125-B2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ctro.2019.10.004","article-title":"Spatially fractionated radiation therapy: History, present and the future","volume":"20","author":"Yan","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"2026081915320558100_tqag125-B3","doi-asserted-by":"publisher","first-page":"102616","DOI":"10.1016\/j.ejmp.2023.102616","article-title":"Clinical aspects of spatially fractionated radiation therapy treatments","volume":"111","author":"Grams","year":"2023","journal-title":"Phys Med"},{"key":"2026081915320558100_tqag125-B4","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.7759\/cureus.417","article-title":"High-dose radiation as a dramatic, immunological primer in locally advanced melanoma","volume":"7","author":"Mohiuddin","year":"2015","journal-title":"Cureus"},{"key":"2026081915320558100_tqag125-B5","doi-asserted-by":"publisher","first-page":"548132","DOI":"10.3389\/fonc.2020.548132","article-title":"Combined high-dose lattice radiation therapy (HDLRT) and immune checkpoint blockade for advanced bulky tumors: the concept and a case report","volume":"10","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"2026081915320558100_tqag125-B6","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.7759\/cureus.9","article-title":"On modern technical approaches of three-dimensional high-dose lattice radiotherapy (LRT)","volume":"2","author":"Wu","year":"2010","journal-title":"Cureus"},{"key":"2026081915320558100_tqag125-B7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0360-3016(99)00170-4","article-title":"High-dose spatially-fractionated radiation (GRID): a new paradigm in the management of advanced cancers","volume":"45","author":"Mohiuddin","year":"1999","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"2026081915320558100_tqag125-B8","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ijrobp.2009.03.030","article-title":"Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity","volume":"76","author":"Pe\u00f1agar\u00edcano","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026081915320558100_tqag125-B9","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.7759\/cureus.389","article-title":"The use of lattice radiation therapy (LRT) in the treatment of bulky tumors: a case report of a large metastatic mixed mullerian ovarian tumor","volume":"7","author":"Suarez","year":"2015","journal-title":"Cureus"},{"key":"2026081915320558100_tqag125-B10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1120\/jacmp.v17i1.5934","article-title":"Spatially fractionated radiotherapy (GRID) using helical tomotherapy","volume":"17","author":"Zhang","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"2026081915320558100_tqag125-B11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ctro.2018.01.003","article-title":"Improved outcome of treating locally advanced lung cancer with the use of lattice radiotherapy (LRT): a case report","volume":"9","author":"Amendola","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"2026081915320558100_tqag125-B12","doi-asserted-by":"publisher","first-page":"e4263","DOI":"10.7759\/cureus.4263","article-title":"Safety and efficacy of lattice radiotherapy in voluminous non-small cell lung cancer","volume":"11","author":"Amendola","year":"2019","journal-title":"Cureus"},{"key":"2026081915320558100_tqag125-B13","doi-asserted-by":"publisher","first-page":"e4637","DOI":"10.7759\/cureus.4637","article-title":"Clinical outcomes of spatially fractionated GRID radiotherapy in the treatment of bulky tumors of the head and neck","volume":"11","author":"Choi","year":"2019","journal-title":"Cureus"},{"key":"2026081915320558100_tqag125-B14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1667\/RADE-20-00100.1","article-title":"Spatially fractionated radiotherapy (GRID) prior to standard neoadjuvant conventionally fractionated radiotherapy for bulky, high-risk soft tissue and osteosarcomas: feasibility, safety, and promising pathologic response rates","volume":"194","author":"Snider","year":"2020","journal-title":"Radiat Res"},{"key":"2026081915320558100_tqag125-B15","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/j.prro.2020.10.007","article-title":"VMAT grid therapy: a widely applicable planning approach","volume":"11","author":"Grams","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"2026081915320558100_tqag125-B16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.radonc.2021.11.023","article-title":"LITE SABR M1: a phase I trial of lattice stereotactic body radiotherapy for large tumors","volume":"167","author":"Duriseti","year":"2022","journal-title":"Radiotherapy and Oncology"},{"key":"2026081915320558100_tqag125-B17","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.3390\/cancers14163909","article-title":"Impressive results after \u201cmetabolism-guided\u201d lattice irradiation in patients submitted to palliative radiation therapy: preliminary results of LATTICE_01 multicenter study","volume":"14","author":"Ferini","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026081915320558100_tqag125-B18","doi-asserted-by":"publisher","first-page":"100639","DOI":"10.1016\/j.adro.2020.100639","article-title":"Spatially fractionated stereotactic body radiation therapy (lattice) for large tumors","volume":"6","author":"Duriseti","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"2026081915320558100_tqag125-B19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2021.12.003","article-title":"LITE SABR M1: Planning design and dosimetric endpoints for a phase I trial of lattice SBRT","volume":"167","author":"Kavanaugh","year":"2022","journal-title":"Radiother Oncol"},{"key":"2026081915320558100_tqag125-B20","doi-asserted-by":"publisher","author":"Fiorini","DOI":"10.2139\/ssrn.5404840"},{"key":"2026081915320558100_tqag125-B21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/1533034616681670","article-title":"Proton grid therapy: a proof-of-concept study","volume":"16","author":"Henry","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"2026081915320558100_tqag125-B22","doi-asserted-by":"publisher","first-page":"20190572","DOI":"10.1259\/bjr.20190572","article-title":"Early clinical results of proton spatially fractionated GRID radiation therapy (SFGRT)","volume":"93","author":"Mohiuddin","year":"2020","journal-title":"Br J Radiol."},{"key":"2026081915320558100_tqag125-B23","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1016\/j.prro.2022.03.005","article-title":"A dosimetric comparison of lattice, brass and proton grid therapy treatment plans","volume":"12","author":"Grams","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"2026081915320558100_tqag125-B24","doi-asserted-by":"publisher","first-page":"101632","DOI":"10.1016\/j.adro.2024.101632","article-title":"Rotationally intensified proton lattice: a novel lattice technique using spot-scanning proton arc therapy","volume":"9","author":"Lee","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"2026081915320558100_tqag125-B25","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1002\/mp.14192","article-title":"Optimization of hexagonal-pattern minibeams for spatially fractionated radiotherapy using proton beam scanning","volume":"47","author":"Charyyev","year":"2020","journal-title":"Med Phys"},{"key":"2026081915320558100_tqag125-B26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.meddos.2018.03.006","article-title":"3D treatment planning system\u2014varian eclipse for proton therapy planning","volume":"43","author":"Sahoo","year":"2018","journal-title":"Med Dosim"},{"key":"2026081915320558100_tqag125-B27","doi-asserted-by":"publisher","first-page":"20200228","DOI":"10.1259\/bjr.20200228","article-title":"Automated Monte-Carlo re-calculation of proton therapy plans using Geant4\/gate: implementation and comparison to plan-specific quality assurance measurements","volume":"93","author":"Aitkenhead","year":"2020","journal-title":"Br J Radiol"},{"key":"2026081915320558100_tqag125-B28","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1002\/mp.14242","article-title":"Technical note: GATE-RTion: a GATE\/Geant4 release for clinical applications in scanned ion beam therapy","volume":"47","author":"Grevillot","year":"2020","journal-title":"Med Phys"},{"key":"2026081915320558100_tqag125-B29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.nima.2016.06.125","article-title":"Recent developments in GEANT4","volume":"835","author":"Allison","year":"2016","journal-title":"Nuclear Instrum Methods Phys Res A"},{"key":"2026081915320558100_tqag125-B30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ejmp.2016.02.008","article-title":"Reference radiochromic film dosimetry: Review of technical aspects","volume":"32","author":"Devic","year":"2016","journal-title":"Phys Med"},{"key":"2026081915320558100_tqag125-B31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1118\/1.4903758","article-title":"Correcting lateral response artifacts from flatbed scanners for radiochromic film dosimetry","volume":"42","author":"Lewis","year":"2015","journal-title":"Med Phys"},{"key":"2026081915320558100_tqag125-B32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1118\/1.598248","article-title":"A technique for the quantitative evaluation of dose distributions","volume":"25","author":"Low","year":"1998","journal-title":"Med Phys"},{"key":"2026081915320558100_tqag125-B33","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1088\/0031-9155\/56\/14\/012","article-title":"Experimental verification of IMPT treatment plans in an anthropomorphic phantom in the presence of delivery uncertainties","volume":"56","author":"Albertini","year":"2011","journal-title":"Phys Med Biol"},{"key":"2026081915320558100_tqag125-B34","doi-asserted-by":"publisher","first-page":"100569","DOI":"10.1016\/j.ctro.2022.100569","article-title":"Lattice radiation therapy in clinical practice: a systematic review","volume":"39","author":"Iori","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"2026081915320558100_tqag125-B35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ijrobp.2023.12.013","article-title":"Overview and recommendations for prospective multi-institutional spatially fractionated radiation therapy clinical trials","volume":"119","author":"Li","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026081915320558100_tqag125-B36","doi-asserted-by":"publisher","first-page":"1731259","DOI":"10.3389\/fonc.2025.1731259","article-title":"Novel pencil-beam scanning proton lattice radiation therapy for the treatment of bulky liver cancer: dosimetric comparison with VMAT-lattice radiotherapy","volume":"15","author":"Li","year":"2026","journal-title":"Front Oncol"},{"key":"2026081915320558100_tqag125-B37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijrobp.2019.01.073","article-title":"A current review of spatial fractionation: Back to the future?","volume":"104","author":"Billena","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026081915320558100_tqag125-B38","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1088\/0031-9155\/53\/24\/001","article-title":"Analysis of uncertainties in Gafchromic EBT film dosimetry of photon beams","volume":"53","author":"Marti\u0161\u00edkov\u00e1","year":"2008","journal-title":"Phys Med Biol"},{"key":"2026081915320558100_tqag125-B39","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.21037\/apm-23-230","article-title":"Proton therapy in the palliative setting","volume":"12","author":"Lubas","year":"2023","journal-title":"Ann Palliat Med"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqag125\/68383544\/tqag125.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1185\/1806\/68383544\/tqag125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1185\/1806\/68383544\/tqag125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:32:13Z","timestamp":1787167933000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/99\/1185\/1806\/8692818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":39,"journal-issue":{"issue":"1185","published-online":{"date-parts":[[2026,5,23]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqag125","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,5,23]]}}}